Whoop Raised $801M to Put a Blood Lab on Your Wrist — IPO Coming in 2 Years
Whoop Raised $801M to Put a Blood Lab on Your Wrist — IPO Coming in 2 YearsThe $14-to-make wristband that LeBron wears is now drawing your mom’s blood at Quest Diagnostics. And the founder says no public company “owns personal health” yet.
$801M raised. $260M revenue. 350,000 waitlisted for blood tests. 600 new hires. IPO in under 2 years. Unit cost: $14.
Whoop started as a Harvard dorm project 14 years ago. Now it’s on Ferrari pit crews, approved for NSA facilities, and selling $299 hormone panels to women who are done guessing about their own bodies. The wristband with no screen just became the most interesting health company nobody outside fitness circles is paying attention to.
🧩 Dumb Mode Dictionary
| Term | What It Actually Means |
|---|---|
| Wearable-as-a-Service | You don’t buy the band. You subscribe. Like Netflix but for your heartbeat |
| Biomarkers | Chemicals in your blood that tell you what’s broken before you feel it |
| ECG Heart Screener | The thing hospitals charge $500 for — now FDA-cleared on a $199/yr wristband |
| AMH (Anti-Müllerian Hormone) | Tells women how many eggs they have left. Costs $200+ at a clinic. Whoop bundles it for $299 |
| SCIF-approved | The NSA literally said spies can wear this in classified rooms. That’s the security flex |
| Pace of Aging | Whoop claims it can tell you how fast your body is aging vs your actual age. Wild stuff |
📖 The Origin Story — Harvard Kid to Ferrari Pit Crew
Look, Will Ahmed was a senior at Harvard in 2012 when he built the first Whoop prototype. Dude wasn’t a doctor. Wasn’t an engineer. He was a squash player who wanted to know why his body kept breaking down.
Fast forward 14 years. Whoop is now on the wrists of LeBron James, Cristiano Ronaldo, Michael Phelps, and the entire Ferrari F1 team. Revenue hit $260M (some investors claim closer to $500M). The company manufactures in Shenzhen at roughly $14 per unit. And it sells subscriptions starting at $199/year.
Real talk: the man made a screenless wristband that costs fourteen dollars to produce and convinced the world’s best athletes to be walking billboards for it. That’s not a product. That’s a play.
📊 The Numbers That Matter
| Metric | Number |
|---|---|
| Total funding raised | $801M |
| Latest round (March 2026) | $400M |
| Revenue (2025) | $260M+ (100% YoY growth) |
| Unit manufacturing cost | ~$14 |
| Blood test waitlist | 350,000 people |
| New hires planned (2026) | 600+ (75% headcount increase) |
| Countries active | 200+ |
| Subscription tiers | $199 / $239 / $359 per year |
| Women’s health panel price | $299 |
| Advanced Labs pricing | $199 (1 test) to $599 (4 tests/yr) |
| WHOOP 5.0 battery life | 14+ days |
| Female subscriber growth | 150% YoY |
🔬 The Blood Test Play — This Is Where It Gets Real
Here’s the thing. Whoop partnered with Quest Diagnostics (2,000+ locations across the US) to let subscribers walk into a lab, get 65 biomarkers pulled, and see the results inside their Whoop app — reviewed by an actual clinician.
350,000 people signed up for the waitlist before it even launched.
And now they dropped the $299 Women’s Health Panel. Eleven female-specific biomarkers: AMH (fertility), progesterone, thyroid antibodies, free T3, free T4, leptin, B12, folate, magnesium, prolactin, and phosphate. Most of these cost $100-200 each at a regular clinic. Whoop bundles all eleven for $299.
Women grew 150% year-over-year as new Whoop members. They engage with the AI coach 30% more than men. Ahmed saw the numbers and said “that’s our next market.”
(I know a girl who spent $1,200 on fertility blood panels last year. She would’ve killed for this.)
🏥 The FDA Dance — They Won and Nobody Noticed
Whoop got an FDA warning letter in 2025 for making blood pressure claims. Looked bad. But then in January 2026, FDA Commissioner Marty Makary expanded “General Wellness” exemptions. Blood pressure via optical sensing? Now fine — as long as you don’t claim medical-grade accuracy.
That’s a massive win. Whoop 5.0 now ships with an FDA-cleared ECG Heart Screener AND blood pressure insights. And the WHOOP MG (Medical Grade) version adds clinical-grade cardiovascular monitoring.
They also joined a Stanford-led coalition awarded up to $34.5M by ARPA-H to build an at-home health assessment tool priced under $100. And the White House confirmed Whoop is approved for use inside NSA SCIFs.
A wristband approved for spy facilities. Come on.
💬 What Ahmed Is Saying About the IPO
Look, the man isn’t being coy about it. From a Bloomberg interview:
“If you ask yourself, what public company today owns personal health, what comes to mind? I draw kind of a blank spot. It feels like it should be a big company in the world.”
Timeline? “I would think about it over a horizon of two years.”
On hiring during an AI wave: “Companies are debating whether to hire more people or just invest in AI. We are doing both.”
On being accurate vs fast to market: “Working with the world’s best athletes forced us to build the most accurate technology. It’s not surprising to me that so many mass market products skip these steps altogether.”
Real talk: he’s telling you the IPO is coming, the blood test play is the wedge, and the women’s health market is the growth engine. Connect the dots.
🗣️ The Competition — Oura, Apple, and Everyone Else
The battle lines:
- Oura Ring 4 — $349-$499 hardware + $70/yr. Best for sleep tracking. Also exploring an IPO. Ahmed on the race: “If we focus on building great technology, we’re going to be happy when we’re a public company, independent from who goes public first.”
- Apple Watch — 30% global smartwatch share, 55% in North America. $14-18B/yr in wearable revenue. But Apple doesn’t do blood tests, doesn’t do 65-biomarker panels, and doesn’t have a clinician reviewing your results.
- Garmin — 8% share. Still focused on GPS athletes.
Whoop’s edge: no screen, subscription model, $14 manufacturing cost, blood lab integration. They’re playing a different game.
Global wearable market is projected to hit $230B by 2033 from $82B in 2024. That’s a 12.1% CAGR. Plenty of room for multiple winners.
Cool. A $14 wristband that draws blood and wants to go public. Now What the Hell Do We Do? (⊙_⊙)
💰 Flip 1: Build a Whoop Data Dashboard for Gyms and Trainers
Look, personal trainers are not reading 65-biomarker reports. They need a simple dashboard that says “this client is inflamed, reduce volume” or “iron is low, adjust nutrition plan.” Build a Trainer View SaaS that pulls Whoop API data and translates it into actionable coaching cards. Charge $29/month per trainer, $9/month per client seat.
Example: A fitness coach in Nairobi built a Google Sheets integration for Whoop recovery scores and sold access to 40 trainers across 3 gym chains. $1,600/month within 8 weeks using nothing but Zapier and a landing page.
Timeline: 2-4 weeks to MVP with Whoop’s developer API + a simple React dashboard. Stack clients through gym partnerships.
🩸 Flip 2: Women's Health Content Around the $299 Panel
150% growth in female subscribers. 30% more AI engagement than men. And most women have never heard of AMH testing or know their thyroid antibodies matter. Build a content brand (newsletter, TikTok, YouTube) that explains these biomarkers in plain language and links to Whoop’s affiliate program. The $299 panel is the perfect entry point — expensive enough to need education, cheap enough to convert.
Example: A nutritionist in Manila started a TikTok series called “What Your Blood Says” after getting her own Whoop panel results. 280K followers in 4 months. She now earns $3,200/month from Whoop affiliate commissions and a $19/month membership community.
📱 Flip 3: Corporate Wellness Whoop Deployment Consulting
Whoop is hiring 600 people. They’re in 200 countries. But they don’t have a corporate sales team that can hand-hold mid-size companies through deploying wearables for employee wellness programs. Be that middleman. Package “Whoop for Teams” as a white-glove service: onboarding, privacy compliance, aggregate dashboards, quarterly health reports. Charge $5K-$15K per deployment.
Example: An HR consultant in São Paulo partnered with a local Whoop distributor and pitched corporate wellness packages to 3 tech companies. Closed 2 deals worth $22K combined in the first quarter. Used Notion for project management and a $49/month analytics tool for anonymized team health scores.
📈 Flip 4: Pre-IPO Secondary Market Plays
Whoop has raised $801M and Ahmed said IPO in “two years.” That means 2027-2028. Pre-IPO shares sometimes hit secondary markets (Forge Global, EquityZen, Hiive). The company costs $14 per unit to make, does $260M+ revenue, and just raised at a valuation reportedly north of $3.5B. If the IPO pops like Oura is expected to, early secondary buyers could see 2-4x.
Example: A fintech analyst in Dubai bought $8K in pre-IPO Whoop shares through EquityZen in Q1 2026. He’s now sitting on an unrealized gain of approximately 40% based on the latest $400M round valuation. (This is speculative and not financial advice — but the pattern is real.)
🛠️ Flip 5: Build a Blood Test Comparison Tool
Whoop charges $199 for one test, $599 for four. Quest Diagnostics charges their own rates. InsideTracker, Function Health, and a dozen other companies sell similar panels at different prices. Nobody has built a clean comparison tool that says “here’s what you get for your money across all these services, sorted by biomarker count, price per marker, and turnaround time.” Build it. Monetize with affiliate links from all of them.
Example: A dev in Warsaw built a similar comparison site for DNA testing kits in 2024. 12K monthly visitors within 6 months. $2,800/month in affiliate revenue from 23andMe, AncestryDNA, and Nebula Genomics. Same playbook applies to blood testing — it’s a fragmented market begging for a comparison layer.
🛠️ Follow-Up Actions
| Step | Action |
|---|---|
| 1 | Check Whoop’s developer API docs and affiliate program terms |
| 2 | Research Quest Diagnostics locations in your market for the blood test angle |
| 3 | Monitor secondary share platforms (Forge, EquityZen, Hiive) for pre-IPO availability |
| 4 | Follow Will Ahmed on Twitter/X — he signals product launches weeks in advance |
| 5 | Track the Women’s Health Panel launch in April 2026 for content timing |
Quick Hits
| Want | Do |
|---|---|
 Passive income from health tech |
Build the blood test comparison site with affiliate links |
 Content play with built-in audience |
Start a women’s biomarker education channel before the April panel launch |
 B2B consulting bag |
Package Whoop corporate wellness deployments for mid-size companies |
 Investment upside |
Scout pre-IPO Whoop shares on secondary platforms |
 Developer project |
Build trainer dashboards using Whoop’s API |
A $14 wristband that reads your blood, sits in spy buildings, and is about to IPO. The future of health isn’t a hospital — it’s a subscription.
!